Siga's financial stability is threatened by potential policy changes, while Emergent's favorable valuation metrics position ...
A recent study presented by Orit Cohen Barak in the ACR Convergence 2024 showed that with the extra advantage of a ...
Upadacitinib was superior to dupilumab for the treatment of atopic dermatitis in the head and neck, trunk, upper limbs, and lower limbs.
Baricitinib is an effective treatment option for children and adolescents with atopic dermatitis, with no new safety signals identified.